L. Moltó

发表

GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.

B. Rini, J. Finke, C. Tannenbaum, 2008, Cancer research.

GM 1 and Tumor Necrosis Factor-A , Overexpressed in Renal Cell Carcinoma , Synergize to Induce T-Cell Apoptosis

B. Rini, J. Finke, C. Tannenbaum, 2008 .

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways

J. Finke, C. Tannenbaum, T. Das, 2008 .

The T cell death knell: immune-mediated tumor death in renal cell carcinoma.

N. Bander, A. Novick, R. Uzzo, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

The T Cell Death Knell

N. Bander, A. Novick, R. Uzzo, 2001 .

Interferon-γ and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma

T. Olencki, A. Novick, J. Finke, 1999 .

Interferon-g and CXC Chemokine Induction by Interleukin 12 in Renal Cell Carcinoma

T. Olencki, A. Novick, J. Finke, 1999 .

Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.

T. Olencki, J. Finke, C. Tannenbaum, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hemolytic anemia in chronic large granular lymphocytic leukemia of natural killer cells: Cytotoxicity of natural killer cells against autologous red cells is associated with hemolysis

M. Álvarez-Mon, F. Gilsanz, L. Moltó, 1996, Transfusion.

The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients

M. Álvarez-Mon, J. Carballido, E. Reyes, 1999, British Journal of Cancer.

Interleukin 2 and interferon alpha modulation of the lymphocyte non-major histocompatibility-restricted lytic activity in glioblastoma patients.

M. Álvarez-Mon, J. Vaquero, R. Martínez, 1992, International journal of immunopharmacology.

Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.

M. Álvarez-Mon, J. Carballido, M. Rodríguez-Zapata, 1994, British Journal of Cancer.

The Interferons: Basic Concepts Concerning their Modulatory Effects on the Immunological System

M. Álvarez-Mon, J. Carballido, M. Rodríguez-Zapata, 1994 .

Interferon β enhances the natural killer activity of patients with bladder carcinoma

M. Álvarez-Mon, J. Carballido, L. Manzano, 1994, Cancer Immunology, Immunotherapy.

Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder.

M. Lapuerta, M. Álvarez-Mon, J. Carballido, 1993, International journal of immunopharmacology.

Use of intracavitary lnterferon‐alpha‐2b in the prophylactic treatment of patients with superficial bladder cancer

M. Álvarez-Mon, J. Carballido, L. Manzano, 1995 .

Interferon‐alpha‐2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder

J. Carballido, L. Manzano, C. Olivier, 1993, Cancer.

Renal Cell Carcinoma Tumors Induce T Cell Apoptosis through Receptor-Dependent and Receptor-Independent Pathways1

J. Finke, C. Tannenbaum, T. Das, 2008, The Journal of Immunology.

Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.

M. Álvarez-Mon, J. Carballido, L. Manzano, 1991, European urology.

Pregnancy Is Associated With a Reduction in the Pattern of the Cytotoxic Activity Displayed by Lymphokine‐Activated Killer Cells

M. Álvarez-Mon, L. Manzano, O. Salmerón, 1991, American journal of reproductive immunology.

Alterations in T-Cell Signaling Pathways and Increased Sensitivity to Apoptosis

I. Derweesh, T. Olencki, J. Finke, 2004 .

CarcinomasExpressed on Renal Cell B in T Cells by κ Degradation of NF

I. Derweesh, C. Tannenbaum, P. Rayman, 2013 .

Degradation of NF-κB in T Cells by Gangliosides Expressed on Renal Cell Carcinomas1

I. Derweesh, J. Finke, C. Tannenbaum, 2004, The Journal of Immunology.

Carcinomas Gangliosides Expressed on Renal Cell B in T Cells by κ Degradation of NF-Finke

I. Derweesh, J. Finke, C. Tannenbaum, 2004 .

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

N. Bander, A. Novick, R. Uzzo, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.

T. Olencki, J. Finke, C. Tannenbaum, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis.

John C. Thomas, J. Finke, C. Tannenbaum, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Receptor-Independent Pathways Apoptosis through Receptor-Dependent and Renal Cell Carcinoma Tumors Induce T Cell

J. Finke, C. Tannenbaum, T. Das, 2008 .

T lymphocytes from autoimmune thrombocytopenic purpura show a defective activation and proliferation after cytoplasmic membrane and intracytoplasmic mitogenic signals

M. Álvarez-Mon, A. Prieto, E. Reyes, 1993, American journal of hematology.

T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.

M. Álvarez-Mon, J. Carballido, A. Prieto, 1997, European urology.

Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.

T. Olencki, A. Novick, J. Finke, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunomodulatory effect of interferon-α2b on natural killer cells and T lymphocytes from patients with transitional cell carcinoma of the bladder

M. Álvarez-Mon, J. Carballido, L. Manzano, 1992, Anti-cancer drugs.

Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2.

M. Álvarez-Mon, J. Carballido, L. Manzano, 1999, Journal of immunotherapy.

Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.

A. Novick, R. Uzzo, J. Finke, 2000, The cancer journal from Scientific American.

Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

I. Derweesh, J. Finke, C. Tannenbaum, 2004, Journal of immunology.

Prophylactic intracavitary treatment with interferon alpha increases interferon gamma production by peripheral blood mononuclear cells in patients with superficial transitional cell carcinoma of the bladder.

M. Álvarez-Mon, J. Carballido, E. Reyes, 1997, British Journal of Cancer.